These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 31121898)

  • 1. Atorvastatin and Fenofibrate Increase the Content of Unsaturated Acyl Chains in HDL and Modify In Vivo Kinetics of HDL-Cholesteryl Esters in New Zealand White Rabbits.
    Flores-Castillo C; Luna-Luna M; Carreón-Torres E; López-Olmos V; Frías S; Juárez-Oropeza MA; Franco M; Fragoso JM; Vargas-Alarcón G; Pérez-Méndez Ó
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31121898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atorvastatin and fenofibrate combination induces the predominance of the large HDL subclasses and increased apo AI fractional catabolic rates in New Zealand white rabbits with exogenous hypercholesterolemia.
    Flores-Castillo C; Zamora-Pérez JÁ; Carreón-Torres E; Arzola-Paniagua A; Aguilar-Salinas C; López-Olmos V; Fragoso JM; Luna-Luna M; Rodríguez-Pérez JM; Franco M; Vargas-Alarcón G; Pérez-Méndez Ó
    Fundam Clin Pharmacol; 2015 Aug; 29(4):362-70. PubMed ID: 25982284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential regulation of lipoprotein kinetics by atorvastatin and fenofibrate in subjects with the metabolic syndrome.
    Watts GF; Barrett PH; Ji J; Serone AP; Chan DC; Croft KD; Loehrer F; Johnson AG
    Diabetes; 2003 Mar; 52(3):803-11. PubMed ID: 12606523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fenofibrate reduces plasma cholesteryl ester transfer from HDL to VLDL and normalizes the atherogenic, dense LDL profile in combined hyperlipidemia.
    Guérin M; Bruckert E; Dolphin PJ; Turpin G; Chapman MJ
    Arterioscler Thromb Vasc Biol; 1996 Jun; 16(6):763-72. PubMed ID: 8640404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrate treatment induced quantitative and qualitative HDL changes associated with an increase of SR-BI cholesterol efflux capacities in rabbits.
    Fournier N; Tuloup-Minguez V; Pourci ML; Thérond P; Jullian JC; Wien F; Leroy M; Dallongeville J; Paul JL; Leroy A
    Biochimie; 2013 Jun; 95(6):1278-87. PubMed ID: 23410672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High density lipoprotein cholesteryl ester metabolism in the pony, an animal species without plasma cholesteryl ester transfer protein activity: transfer of high density lipoprotein cholesteryl esters to lower density lipoproteins and the effect of the amount of fat in the diet.
    Geelen SN; Lemmens AG; Terpstra AH; Wensing T; Beynen AC
    Comp Biochem Physiol B Biochem Mol Biol; 2001 Sep; 130(2):145-54. PubMed ID: 11544085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of atorvastatin versus fenofibrate on apoB-100 and apoA-I kinetics in mixed hyperlipidemia.
    Bilz S; Wagner S; Schmitz M; Bedynek A; Keller U; Demant T
    J Lipid Res; 2004 Jan; 45(1):174-85. PubMed ID: 14523053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Action of atorvastatin in combined hyperlipidemia : preferential reduction of cholesteryl ester transfer from HDL to VLDL1 particles.
    Guerin M; Lassel TS; Le Goff W; Farnier M; Chapman MJ
    Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):189-97. PubMed ID: 10634817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological modulation of cholesteryl ester transfer protein, a new therapeutic target in atherogenic dyslipidemia.
    Le Goff W; Guerin M; Chapman MJ
    Pharmacol Ther; 2004 Jan; 101(1):17-38. PubMed ID: 14729390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of cholesteryl ester transfer protein-mediated cholesteryl ester mass transfer from high-density lipoprotein to low-density lipoprotein particles is a major feature of combined hyperlipidaemia.
    Guérin M; Bruckert E; Dolphin PJ; Chapman MJ
    Eur J Clin Invest; 1996 Jun; 26(6):485-94. PubMed ID: 8817163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Total Outflow of High-Density Lipoprotein-Cholesteryl Esters from Plasma Is Decreased in a Model of 3/4 Renal Mass Reduction.
    Luna-Luna M; Franco M; Carreón-Torres E; Pérez-Hernández N; Fragoso JM; Bautista-Pérez R; Pérez-Méndez Ó
    Int J Mol Sci; 2023 Dec; 24(23):. PubMed ID: 38069414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atorvastatin and Fenofibrate Exert Opposite Effects on the Vascularization and Characteristics of Visceral Adipose Tissue in New Zealand White Rabbits.
    Mondragón-García A; Luna-Luna M; Flores-Castillo C; Aranda-Fraustro A; Carreón-Torres E; López-Olmos V; Fragoso JM; Vargas-Alarcón G; Pérez-Méndez Ó
    J Cardiovasc Pharmacol Ther; 2019 Nov; 24(6):559-566. PubMed ID: 31056933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of dietary omega-3 eicosapentaenoic acid supplements on cholesteryl ester transfer from HDL in cholesterol-fed rabbits.
    Sugano M; Makino N; Yanaga T
    Biochim Biophys Acta; 1997 May; 1346(1):17-24. PubMed ID: 9187298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux.
    Guerin M; Egger P; Soudant C; Le Goff W; van Tol A; Dupuis R; Chapman MJ
    Atherosclerosis; 2002 Aug; 163(2):287-96. PubMed ID: 12052475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of apo CIII reduction to the greater effect of 12-week micronized fenofibrate than atorvastatin therapy on triglyceride levels and LDL size in dyslipidemic patients.
    Lemieux I; Salomon H; Després JP
    Ann Med; 2003; 35(6):442-8. PubMed ID: 14572169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of atorvastatin on high-density lipoprotein apolipoprotein A-I production and clearance in the New Zealand white rabbit.
    Rashid S; Uffelman KD; Barrett PH; Lewis GF
    Circulation; 2002 Dec; 106(23):2955-60. PubMed ID: 12460878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of lipoprotein lipase and hepatic lipase on the transformation of VLDL and HDL during lipolysis of VLDL.
    Murdoch SJ; Breckenridge WC
    Atherosclerosis; 1995 Dec; 118(2):193-212. PubMed ID: 8770314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of various non-esterified fatty acids on the transfer of cholesteryl esters from HDL to LDL induced by the cholesteryl ester transfer protein.
    Lagrost L; Barter PJ
    Biochim Biophys Acta; 1991 Sep; 1085(2):209-16. PubMed ID: 1892890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effect of fenofibrate and atorvastatin on in vivo kinetics of apolipoproteins B-100 and B-48 in subjects with type 2 diabetes mellitus with marked hypertriglyceridemia.
    Hogue JC; Lamarche B; Deshaies Y; Tremblay AJ; Bergeron J; Gagné C; Couture P
    Metabolism; 2008 Feb; 57(2):246-54. PubMed ID: 18191056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of pathways for the cellular uptake of high density lipoprotein cholesterol esters in rabbits.
    Goldberg DI; Beltz WF; Pittman RC
    J Clin Invest; 1991 Jan; 87(1):331-46. PubMed ID: 1985105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.